COLUMBUS, Ohio – GenomeNext, LLC, a leader in genomic data management and integrated analysis, announced today that it’s genomic analysis pipeline delivered the bioinformatics and genomic sequence analysis capability supporting Nationwide Children’s efforts to win the CLARITY Undiagnosed Challenge. An estimated 25-30 million Americans suffer from a rare disorder in the United States alone, according […]
Craigavon, N.I., UK, –– Almac Diagnostics announced that it had entered into a collaboration with Illumina, Inc. (NASDAQ: ILMN) to establish a framework for the development of next-generation sequencing (NGS)-based companion diagnostic assays. The collaboration enables Almac to develop next-generation sequencing (NGS) assays using the Illumina MiSeqDx® instrument, the first FDA-cleared IVD NGS system designed […]
Genomics England has today announced that it has contracted with WuXi NextCODE as a Clinical Interpretation Partner for the 100,000 Genomes Project. The China, US and Iceland-based company is the first to work with them on cancer samples and will also interpret samples in rare disease. Genomics England will work with the clinical interpretation partners […]
Sapio Sciences has announced the release of Exemplar Next Generation Sequencing (NGS) LIMS 2.0. Exemplar NGS LIMS 2.0 was designed and built from valuable lessons learned working with Sapio’s industry leading NGS customers in both the clinical and research space. Exemplar NGS LIMS 2.0 is also now optionally able to be deployed in a cloud […]
Wilmington, DE — The Pistoia Alliance, a not for profit organization working to improve collaboration in the life sciences industry, has started work on the Chemical Safety Library, a project which will allow for the capture and sharing of previously inaccessible reaction incident information to enhance laboratory safety. The research enterprise inherently will always involve […]
IPSWICH, Mass. — New England Biolabs (NEB®) today launched the NEBNext Selector, an online, interactive tool that helps researchers easily determine the optimal NEBNext product for every step in their next generation sequencing (NGS) sample preparation workflow. “The rapid evolution of NGS technologies can make it difficult for users to keep abreast of the latest […]
LUXEMBOURG — Advanced Biological Laboratories (ABL) announced the launch of the DeepChek® SingleRound HIV and Hepatitis C Virus (HCV) Genotyping and Sequencing assays. These two assays are the first in its virology reagents portfolio. The DeepChek® SingleRound assays are currently available for Research Use Only. The DeepChek® SingleRound HIV RT-PCR and Sequencing Assay detects all […]
ALAMEDA, Calif. & AUSTIN, Tex. – LifeMap Sciences, Inc. (“LifeMap”), a subsidiary of BioTime, Inc., and Lab7 Systems, Inc., announced today a partnership and launch of an integrated solution in the next-generation genomic sequencing (NGS) field, a multi-billion dollar, rapidly growing global market. LifeMap’s VarElect, The NGS Phenotyper, is now integrated into the Lab7 Enterprise […]
Austin, Texas, and Hilden, Germany – QIAGEN N.V. (NASDAQ: QGEN; Frankfurt Prime Standard: QIA) today announced the start of commercialization activities for its GeneReader NGS System, the first complete Sample to Insight next-generation sequencing (NGS) solution designed for any laboratory to deliver actionable results. With the introduction of the GeneReader NGS System*, QIAGEN is offering […]
CARLSBAD, Calif. — Singapore General Hospital (SGH) and Thermo Fisher Scientific today announced the establishment of a collaborative partnership aimed at identifying cancer genetic mutations linked with Asian populations using Thermo Fisher’s Ion Torrent next-generation sequencing (NGS) platform. The research collaboration will take phased approaches to analyze retrospective samples from cancer patients with Asian ancestry […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
